Discussed On
Episodes
Pharma and BioTech Daily · Jul 28, 2026
AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily
Antibody-Drug Conjugates (ADCs) in OncologyNon-Stimulant ADHD TherapeuticsDuchenne Muscular Dystrophy (DMD) TreatmentsWet Age-Related Macular Degeneration (AMD)TYK2 Inhibitors for Psoriasis
View Analysis